aminoimidazole carboxamide has been researched along with Rhabdomyosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Q; Hao, S; Qu, J; Wang, C; Yan, S; Zhou, D | 1 |
| Bryce, NS; Catchpoole, DR; Hambley, TW; Huynh, T; Stewart, BW; Wakelin, LP; Wolf, SJ | 1 |
2 other study(ies) available for aminoimidazole carboxamide and Rhabdomyosarcoma
| Article | Year |
|---|---|
PFK15, a PFKFB3 antagonist, inhibits autophagy and proliferation in rhabdomyosarcoma cells.
Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Autophagy; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Clone Cells; Down-Regulation; Humans; Mechanistic Target of Rapamycin Complex 1; Phosphofructokinase-2; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Quinolines; Rhabdomyosarcoma; Ribonucleotides | 2018 |
Intracellular trafficking as a determinant of AS-DACA cytotoxicity in rhabdomyosarcoma cells.
Topics: Aminoimidazole Carboxamide; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; DNA Breaks, Double-Stranded; Drug Resistance, Neoplasm; Endosomes; Humans; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Neoplastic Stem Cells; rab5 GTP-Binding Proteins; Rhabdomyosarcoma; Vesicular Transport Proteins | 2011 |